Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Bosch-Nicolau P, Herrero-Martínez JM, Arsuaga M, Chamorro-Tojeiro S, Carrillo I, Bea-Serrano C, Llenas-García J, Pérez-Recio S, Fernández-Pedregal E, Crespillo-Andújar C, Silgado A, Pérez-Ayala A, de la Calle-Prieto F, Prieto-Pérez L, Pérez-Molina JA, Molina I.

    The Chagas non-endemic (ChaNoE) cohort: Aims and study protocol

    PLoS One . 20(4): . Nº de citas: 3

    [doi:10.1371/journal.pone.0320637]

  • Rosas Cancio-Suárez M, Moreno A, del Campo Terrón S, Vivancos MJ, G García-Ruiz De Morales A, Martínez-Sanz J, Ron R, Sánchez-Izquierdo S, Vélez-Díaz-Pallarés M, Moreno S, Pérez-Elías MJ.

    Real-world efficacy and tolerability of CAB plus RPV LA in women: addressing the gender gap in HIV treatment research

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(4): 1084-1088. Nº de citas: 2

    [doi:10.1093/jac/dkaf038]

  • Izquierdo R, Suárez-García I, Marco-Sánchez C, Pérez-Latorre L, Riera M, Cano J, Viladés C, Reus S, Olalla J, González-Ruano P, Orviz E, Díaz A, Moreno S, Jarrín I.

    Health-related quality of life in people with HIV from the multicentre CoRIS cohort in Spain: Associated factors and short-term changes over time

    HIV MEDICINE . 26(4): 606-620. Nº de citas: 1

    [doi:10.1111/hiv.13762]

  • Monge-Maillo B, Roger-Zapata D, Dronda F, Carrillo E, Moreno J, Corbacho-Loarte MD, Gayoso Cantero D, Martín O, Chamorro-Tojeiro S, Perez-Molina JA, Norman F, González-Sanz M, López-Vélez R.

    Case Report: Long-Term Follow-Up of Visceral Leishmaniasis and HIV Coinfected Patients Without Relapse: Lymphoproliferative Response After Stimulation with Soluble Leishmania Antigen

    Microorganisms . 13(3): . Nº de citas: 1

    [doi:10.3390/microorganisms13030686]

  • Bailón L, Moltó J, Curran A, Cadiñanos J, Carlos Lopez Bernaldo de Quirós J, de Los Santos I, Ambrosioni J, Imaz A, Benet S, Suanzes P, Navarro J, González-García J, Busca C, Pérez-Latorre L, Berenguer J, García-Fraile LJ, Mejía-Abril G, Miró JM, Scévola S, Moreno S, Domingo P, Tian Y, Frankot M, Lim D, Cai Y, Vendrame E, Guo S, Wallin JJ, Geleziunas R, SenGupta D, Alarcón-Soto Y, Leal I, Aranguen A, Garcia-Garcia M, McGowan I, Brander C, Arribas JR, Mothe B.

    Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial

    Nature Communications . 16(1): 2146-2146. Nº de citas: 25

    [doi:10.1038/s41467-025-57284-w]

  • Tamarozzi F, Mazzi C, Antinori S, Arsuaga M, Becker SL, Bocanegra C, Bottieau E, Buonfrate D, Bustinduy AL, Camprubí-Ferrer D, Caumes E, Duvignaud A, Grobusch MP, Huits R, Jaureguiberry S, Jordan S, Mueller A, Ndao M, Neumayr A, Perez-Molina JA, Pettersen FO, Rothe C, Salas-Coronas J, Salvador F, Stothard JR, Tomasoni LR, van Hellemond JJ, van Lieshout L, Vaughan SD, Wammes LJ, Yansouni CP, Zammarchi L, Gobbi FG.

    Landscape of guidance documents used at TropNet and GeoSentinel centres for the clinical management of schistosomiasis outside endemic areas: A systematic appraisal

    Travel Medicine and Infectious Disease . 64: 102822-102822. Nº de citas: 3

    [doi:10.1016/j.tmaid.2025.102822]

  • Norman FF, Arce OA, Díaz-Menéndez M, Belhassen-García M, González-Sanz M.

    Changes in the epidemiology of Crimean-Congo hemorrhagic fever: Impact of travel and a One Health approach in the European region

    Travel Medicine and Infectious Disease . 64: 102806-102806. Nº de citas: 13

    [doi:10.1016/j.tmaid.2025.102806]

  • Aslan AT, Kara E, Köksal G, Bilir Y, Saraçoglu KT, Eser F, Güner R, Alkan S, D'Avino A, Escudero-Sanchez R, Kutluca K, Kaya SY, Saltoglu N, Loiacono L, Coladonato S, Giacomo PD, Cascio A, Pallotto C, Francisci D, Öztürk B, Pinar A, Dag O, Harris PNA, Paterson DL, Akova M.

    Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study

    International Journal of Antimicrobial Agents . 65(3): 107446-107446. Nº de citas: 4

    [doi:10.1016/j.ijantimicag.2025.107446]

  • Cuervo G, Hernández-Meneses M, de Alarcón A, Luque-Marquez R, Alonso-Socas MM, López-Lirola A, González-Ramallo V, Goikoetxea-Agirre AJ, Nicolás D, Goenaga MA, Merino E, Escrihuela-Vidal F, Martín-Dávila P, Loeches B, Boix-Palop L, Gasch O, Camprecios M, Hernández-Torres A, García-Álvarez L, Pajarón M, Ribas MA, Blanes-Hernández R, López-Montesinos I, López-Cortés LE, Vidal B, Fernández-Pittol M, Navarro D, Moreno A, Sala C, Ambrosioni J, Miró JM.

    Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial

    Infectious Diseases and Therapy . 14(3): 643-655. Nº de citas: 3

    [doi:10.1007/s40121-025-01110-9]

  • Teigell Muñoz FJ, Sánchez-de Torre A, Jiménez-Fernández M, Zuñiga Gómez L, Mateos-González M, Batiray Polat A, Fortún Abete J.

    Aspergillus spondylodiscitis successfully treated with a long course of isavuconazole

    JOURNAL OF INFECTION AND CHEMOTHERAPY . 31(2): . Nº de citas: 2

    [doi:10.1016/j.jiac.2024.11.017]

  • Fernández Plaza J, Guzmán J, Chamorro-Tojeiro S, Pérez-Molina JA.

    HIV and Chagas disease coinfection.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(2): 117-119. Nº de citas: 1

    [doi:10.1016/j.eimce.2024.09.010]

  • Grinspoon SK, Zanni MV, Triant VA, Kantor A, Umbleja T, Diggs MR, Chu SM, Fitch KV, Currier JS, Bloomfield GS, Casado JL, de la Peña M, Fantry LE, Gardner E, Aberg JA, Malvestutto CD, Fichtenbaum CJ, Lu MT, Ribaudo HJ, Douglas PS.

    Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular from REPRIEVE

    Lancet HIV . 12(2): 118-129. Nº de citas: 30

    [doi:10.1016/S2352-3018(24)00276-5]

  • González-Sanz M, Martín-Rubio I, Martín O, Muriel A, de la Fuente-Hernanz S, Crespillo-Andújar C, Chamorro-Tojeiro S, Monge-Maíllo B, Norman FF, Pérez-Molina JA.

    Description of the Serological Response After Treatment of Chronic Imported Schistosomiasis

    Tropical Medicine and Infectious Disease . 10(1): . Nº de citas: 4

    [doi:10.3390/tropicalmed10010022]

  • Henriquez-Camacho C, Pérez-Molina JA, Buonfrate D, Rodari P, Gotuzzo E, Luengo B, Plana MN.

    Ivermectin vs moxidectin for treating Strongyloides stercoralis infection: a systematic review

    PARASITOLOGY . 151(13): 1466-1472. Nº de citas: 4

    [doi:10.1017/S0031182024001215]

  • Hidalgo-Tenorio C, Martínez-Sanz J.

    Simplification of antiretroviral therapy: comparative review of two-drug and three-drug regimens in HIV treatment

    AIDS REVIEWS . 27(1): 16-24. Nº de citas: 4

    [doi:10.24875/AIDSRev.M25000081]

  • Norman FF, González-López JJ, Gayoso-Cantero D, Vicente-Antolin M, Corbacho-Loarte MD, López-Vélez R, González-Sanz M.

    Ocular Infections in International Travelers.

    Travel Medicine and Infectious Disease . 63: 102789-102789.

    [doi:10.1016/j.tmaid.2024.102789]

  • Suárez-García I, Alejos B, Moreno C, Martín Torres J, Masiá M, García-Fraile LJ, Riera M, Dalmau D, Rodríguez-Rosado R, Muga R, Moreno S, Jarrín I.

    Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96 weeks.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . : .

    [doi:10.1093/jac/dkae456]

  • Hess KM, Seed SM, Clark EH, Lombardo T, Norman FF, Flaherty G.

    Multidisciplinary Travel Health Education: Current Status and Rationale for Standardized Competencies.

    JOURNAL OF TRAVEL MEDICINE . 31(8): . Nº de citas: 4

    [doi:10.1093/jtm/taae130]